{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T22:56:54Z","timestamp":1790463414826,"version":"4.1.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"36","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.vaccine.2015.06.078","type":"journal-article","created":{"date-parts":[[2015,7,4]],"date-time":"2015-07-04T18:49:40Z","timestamp":1436035780000},"page":"4610-4617","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Safety and immunogenicity of a trivalent recombinant PcpA, PhtD, and PlyD1 pneumococcal protein vaccine in adults, toddlers, and infants: A phase I randomized controlled study"],"prefix":"10.1016","volume":"33","author":[{"given":"W. Abdullah","family":"Brooks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee-Jah","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hopfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.06.078_bib0090","first-page":"129","article-title":"Pneumococcal vaccines WHO position paper\u20142012","volume":"87","author":"World Health Organization","year":"2012","journal-title":"Releve epidemiologique hebdomadaire\/Section d\u2019hygiene du Secretariat de la Societe des Nations"},{"key":"10.1016\/j.vaccine.2015.06.078_bib0095","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1055\/s-0029-1202938","article-title":"Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention","volume":"30","author":"Lynch","year":"2009","journal-title":"Sem Respir Crit Care Med"},{"key":"10.1016\/j.vaccine.2015.06.078_bib0100","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jinf.2014.06.006","article-title":"Review current and new generation pneumococcal vaccines","volume":"69","author":"Feldman","year":"2011","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2015.06.078_bib0105","first-page":"010401","article-title":"Epidemiology and etiology of childhood pneumonia in 2010: estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries","volume":"3","author":"Rudan","year":"2013","journal-title":"J Global Health"},{"key":"10.1016\/j.vaccine.2015.06.078_bib0110","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/S0140-6736(11)60687-9","article-title":"Making new vaccines affordable: a comparison of financing processes used to develop and deploy new meningococcal and pneumococcal conjugate vaccines","volume":"378","author":"Hargreaves","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.06.078_bib0115","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1089\/mdr.2008.0782","article-title":"Serotype replacement and multiple resistance in Streptococcus pneumoniae after the introduction of the conjugate pneumococcal vaccine","volume":"14","author":"Mera","year":"2008","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.vaccine.2015.06.078_bib0120","doi-asserted-by":"crossref","first-page":"7461","DOI":"10.1016\/j.vaccine.2012.10.076","article-title":"Safety and immunogenicity of pneumococcal protein vaccine candidates: monovalent choline-binding protein A (PcpA) vaccine and bivalent PcpA-pneumococcal histidine triad protein D vaccine","volume":"30","author":"Bologa","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.06.078_bib0125","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.vaccine.2012.11.005","article-title":"Safety and immunogenicity of the pneumococcal pneumolysin derivative PlyD1 in a single-antigen protein vaccine candidate in adults","volume":"31","author":"Kamtchoua","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.06.078_bib0130","doi-asserted-by":"crossref","first-page":"7455","DOI":"10.1016\/j.vaccine.2012.10.080","article-title":"Safety and immunogenicity of a pneumococcal histidine triad protein D vaccine candidate in adults","volume":"30","author":"Seiberling","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.06.078_bib0135","doi-asserted-by":"crossref","first-page":"6838","DOI":"10.1016\/j.vaccine.2014.02.052","article-title":"Safety, reactogenicity and immunogenicity of a novel pneumococcal protein-based vaccine in adults: a phase I\/II randomized clinical study","volume":"32","author":"Leroux-Roels","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.06.078_bib0140","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.vaccine.2013.10.052","article-title":"Adjuvant system AS02 enhances humoral and cellular immune responses to pneumococcal protein PhtD vaccine in healthy young and older adults: randomised, controlled trials","volume":"33","author":"Leroux-Roels","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.06.078_bib0145","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1016\/j.vaccine.2014.04.004","article-title":"Vaccination with a Streptococcus pneumoniae trivalent recombinant PcpA, PhtD and PlyD1 protein vaccine candidate protects against lethal pneumonia in an infant murine model","volume":"32","author":"Verhoeven","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.06.078_bib0150","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1016\/j.vaccine.2012.02.038","article-title":"Formulation, stability and immunogenicity of a trivalent pneumococcal protein vaccine formulated with aluminum salt adjuvants","volume":"30","author":"Ljutic","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.06.078_bib0155","doi-asserted-by":"crossref","first-page":"795","DOI":"10.4269\/ajtmh.2007.77.795","article-title":"Invasive pneumococcal disease burden and implications for vaccine policy in urban Bangladesh","volume":"77","author":"Brooks","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2015.06.078_bib0160","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/INF.0b013e3181bc23fd","article-title":"Influenza is a major contributor to childhood pneumonia in a tropical developing country","volume":"29","author":"Brooks","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2015.06.078_bib0165","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3201\/eid1102.040422","article-title":"Bacteremic typhoid fever in children in an urban slum, Bangladesh","volume":"11","author":"Brooks","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2015.06.078_bib0170","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0140-6736(05)67109-7","article-title":"Effect of weekly zinc supplements on incidence of pneumonia and diarrhoea in children younger than 2 years in an urban, low-income population in Bangladesh: randomised controlled trial","volume":"366","author":"Brooks","year":"2005","journal-title":"Lancet"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15008798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15008798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T00:20:19Z","timestamp":1566951619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15008798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":17,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0264410X15008798"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.06.078","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and immunogenicity of a trivalent recombinant PcpA, PhtD, and PlyD1 pneumococcal protein vaccine in adults, toddlers, and infants: A phase I randomized controlled study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.06.078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}